Kleĭner A I, Makotchenko V M, Efremova V A, Novokhatniaia L V, Shmuter L M
Med Tr Prom Ekol. 1993(2):32-5.
The efficacy of follow-up was evaluated in 83 patients facing complicated dust bronchitis of 2 and 3 grades. An active follow-up group was treated by immunopotentiators in clinic every 3-4 months so as to prevent recurrences, while the passive follow-up group received the stationary treatment only once a year. Observations within 3 years showed a great efficiency of the active follow-up combined with the antirecurrence treatment given 3-4 times a year. Immune status was stressed to improve in connection with the clinical relief.
对83例患有2级和3级复杂性尘支气管炎的患者的随访疗效进行了评估。积极随访组每3 - 4个月在门诊接受免疫增强剂治疗以预防复发,而被动随访组每年仅接受一次常规治疗。3年内的观察表明,每年进行3 - 4次抗复发治疗的积极随访具有很高的疗效。强调免疫状态随着临床症状缓解而改善。